IBM, Coriell, CareKinesis Collaborate to Enhance Medication Safety for Elderly | GenomeWeb

NEW YORK (GenomeWeb) – IBM today announced a collaboration with Coriell Life Sciences and CareKinesis to analyze and store genetic data from elderly patients in an effort to improve and better manage their medication regimens.

Using SoftLayer, an IBM company, the partners are launching an initiative with Program for All Inclusive Care of the Elderly (PACE) "to enhance medication safety by better understanding how high-risk individuals respond to specific medications and drug treatments," they said in a statement. PACE cares for about 5,000 seniors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.